International pharmaceutical corporation Ely Lilly and Company slashed the list price of insulin 70 percent, and capped patient insulin out-of-pocket costs at $35 per month. For University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences Assistant Professor Kelly Anderson, PhD, MPP, the move, in conjunction with state and federal legislative efforts to cap insulin out-of-pocket costs, is a “watershed moment” in making prescription medications accessible and affordable.
Pharmacy and Pharmaceutical Sciences Building
12850 East Montview Boulevard
Aurora, CO 80045